Gilead Sciences Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   USD per share 
 Price  62.55
 Dividend  2.28
 Earnings  8.57
 Cash-flow  9.20
 Book value  15.64
 Equity  15.09

Gilead Sciences is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Gilead Sciences is a company from USA, and his stocks are publicly traded.

Gilead Sciences paid a total dividend of 2,964 million USD last year, for a market value of 81,315 millions (Market Cap 80,839 millions). Dividend per share of Gilead Sciences is 2.28 USD, and his stock market price 62.55 USD.

According to the chart below, where dividend yield is displayed, Gilead Sciences has a dividend yield of 3.65%, which is higher than the amount offered by both the market average and companies from USA. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Gilead Sciences dividend yield with other Pharmaceuticals and Biotechnology companies or firms from USA.

Dividend yield of Gilead Sciences

Gilead Sciences Dividend Payout

About the ability of Gilead Sciences to maintain his current dividend of USD 2.28 per share, an amount that accounts for 3.65%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Gilead Sciences payout on ernings is currently 26.60%, which is lower than the market average and companies of Health Care industry, which are 40.41% and 28.58% respectively. Both figures lead us to believe that there is confidence that Gilead Sciencescan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Gilead Sciences is USD 9.20 per share, which is higher than the dividend per share paid by the company of USD 2.28, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Gilead Sciences, compared againt world market average, USA companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Gilead Sciences payout

Gilead Sciences Stock performance

Finally, last moth Gilead Sciences showed a return of -13.10% compared to a worldwide -5.60% average, and a -7.73% of Health Care firms. Over the last year, the company obtained a -12.70% versus a worldwide performance of a -11.41%. More detailed information can be seen in the following graph for USA and Pharmaceuticals and Biotechnology firms.

Gilead Sciences stock and market return

Next companies

Givaudan N. Switzerland. Basic Materials.

Gjensidige Forsikrin. Norway. Financials.

GKN. UK. Consumer Goods.

Glanbia. Ireland. Consumer Goods.

GlaxoSmithKline. UK. Health Care.

GlaxoSmithKline Phar. India. Health Care.

Previous companies

Giant Manufacturing. Taiwan. Consumer Goods.

GF Securities (H). China. Financials.

Getinge B. Sweden. Health Care.

Getin Noble Bank SA. Poland. Financials.

Gerdau PN. Brazil. Basic Materials.

Genworth Financial A. USA. Financials.



All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.